Zobrazeno 1 - 10
of 757
pro vyhledávání: '"Ruetsch C"'
Publikováno v:
Neuropsychiatric Disease and Treatment, Vol Volume 18, Pp 2467-2475 (2022)
Felicia Forma,1 Joshua N Liberman,2 Pinyao Rui,2 Emily Wiggins,2 Charles Ruetsch2 1Health Economics & Real-World Evidence, Formerly Otsuka Pharmaceutical Development & Commercialization, Inc, Princeton, NJ, USA; 2Health Analytics, LLC, Columbia, MD,
Externí odkaz:
https://doaj.org/article/50691320cf8c4df5b7cb8ca2c3a0e095
Publikováno v:
Neuropsychiatric Disease and Treatment, Vol Volume 17, Pp 3715-3726 (2021)
Charles Ruetsch,1 Tigwa Davis,1 Joshua N Liberman,1 Dawn I Velligan,2 Delbert Robinson,3 Chris Jaeger,4 William Carpenter,5 Felica Forma6 1Health Analytics, LLC, Columbia, MD, USA; 2Department of Psychiatry, University of Texas Health Science Center
Externí odkaz:
https://doaj.org/article/b683c88b735c472f86f53a6730a4d1a5
Publikováno v:
ClinicoEconomics and Outcomes Research, Vol Volume 13, Pp 909-916 (2021)
Fulton F Velez,1 Sam Colman,2 Laura Kauffman,2 Charles Ruetsch,3 Kathryn Anastassopoulos,2 Yuri A Maricich1 1Pear Therapeutics, Inc., Boston, MA, USA; 2Covance Market Access, Gaithersburg, MD, USA; 3Health Analytics, Columbia, MD, USACorrespondence:
Externí odkaz:
https://doaj.org/article/7046d23976454328bed97500285a766e
Publikováno v:
ClinicoEconomics and Outcomes Research, Vol Volume 10, Pp 259-267 (2018)
Charles Ruetsch,1 Hyong Un,2 Heidi C Waters3 1Health Analytics, LLC, Columbia, MD, USA; 2Aetna, Inc, Blue Bell, PA, USA; 3Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ, USA Objective: Schizophrenia (Sz) patients are among
Externí odkaz:
https://doaj.org/article/6ada5f0bd1624e14b5736e2a6b86eec6
Autor:
Shafrin J, May SG, Shrestha A, Ruetsch C, Gerlanc N, Forma F, Hatch A, Lakdawalla DN, Lindenmayer JP
Publikováno v:
Patient Preference and Adherence, Vol Volume 11, Pp 1071-1081 (2017)
Jason Shafrin,1 Suepattra G May,1 Anshu Shrestha,1 Charles Ruetsch,2 Nicole Gerlanc,2 Felicia Forma,3 Ainslie Hatch,4 Darius N Lakdawalla,1,5 Jean-Pierre Lindenmayer6 1Precision Health Economics, Los Angeles, CA, 2Health Analytics, Columbia, MD, 3Ots
Externí odkaz:
https://doaj.org/article/d92faa1140ea445aa34b3cb752717988
Autor:
Velez FF; Pear Therapeutics (US), Inc., 200 State St., Boston, MA, 02109, USA. fulton.velez@peartherapeutics.com., Anastassopoulos KP; Market Access Consulting, Labcorp Drug Development, Gaithersburg, MD, USA., Colman S; Market Access Consulting, Labcorp Drug Development, Gaithersburg, MD, USA., Shah N; Pear Therapeutics (US), Inc., 200 State St., Boston, MA, 02109, USA., Kauffman L; Market Access Consulting, Labcorp Drug Development, Gaithersburg, MD, USA., Murphy SM; Department of Population Health Sciences, Weill Cornell Medical College, New York, NY, USA., Ruetsch C; Health Analytics, Columbia, MD, USA., Maricich YA; Pear Therapeutics (US), Inc., 200 State St., Boston, MA, 02109, USA.
Publikováno v:
Advances in therapy [Adv Ther] 2022 Sep; Vol. 39 (9), pp. 4131-4145. Date of Electronic Publication: 2022 Jul 07.
Publikováno v:
Journal of Pain Research, Vol 2013, Iss default, Pp 137-149 (2013)
Charles Ruetsch,1 Joseph Tkacz,1 Peter G Kardel,1 Andrew Howe,2 Helen Pai,2 Bennett Levitan31Health Analytics, LLC, Columbia, Maryland, 2Janssen Research & Development, Raritan, New Jersey, 3Janssen Research & Development, Titusville, New Jersey, USA
Externí odkaz:
https://doaj.org/article/49bee1305eb44748bb7c3adb50f25560
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Manni S; Department of Infectious Diseases, Cannes General Hospital, Cannes, France., Ruetsch C; Immunology Department, Nice University Hospital, Côte d'Azur University, Nice, France.; Mediterranean Centre for Molecular Medicine (C3M), Institut National de la Santé Et de la Recherche Médicale (INSERM) U1065, Côte d'Azur University, Nice, France., Fabre R; Public Health Department, Nice University Hospital, Côte d'Azur Université, Nice, France., Ticchioni M; Immunology Department, Nice University Hospital, Côte d'Azur University, Nice, France., Graça D; Immunology Department, Nice University Hospital, Côte d'Azur University, Nice, France.; Unité de Recherche Clinique Côte d'Azur (UR2CA), Côte d'Azur University, Nice, France., Pradier C; Public Health Department, Nice University Hospital, Côte d'Azur Université, Nice, France., Seitz-Polski B; Immunology Department, Nice University Hospital, Côte d'Azur University, Nice, France.; Unité de Recherche Clinique Côte d'Azur (UR2CA), Côte d'Azur University, Nice, France., Lotte L; Multipurpose Laboratory, Cannes General Hospital, Cannes, France., Brglez V; Immunology Department, Nice University Hospital, Côte d'Azur University, Nice, France.; Unité de Recherche Clinique Côte d'Azur (UR2CA), Côte d'Azur University, Nice, France., Vassallo M; Department of Infectious Diseases, Cannes General Hospital, Cannes, France.; Unité de Recherche Clinique Côte d'Azur (UR2CA), Côte d'Azur University, Nice, France.
Publikováno v:
Frontiers in immunology [Front Immunol] 2023 Mar 06; Vol. 14, pp. 1136723. Date of Electronic Publication: 2023 Mar 06 (Print Publication: 2023).
Autor:
Forma F; Health Economics, Otsuka Pharmaceutical Development & Commercialization, Inc, Princeton, NJ, USA., Liberman JN; Health Analytics, LLC, Clarksville, MD, USA., Rui P; Health Analytics, LLC, Clarksville, MD, USA., Ruetsch C; Health Analytics, LLC, Clarksville, MD, USA.
Publikováno v:
Expert review of pharmacoeconomics & outcomes research [Expert Rev Pharmacoecon Outcomes Res] 2023 Mar; Vol. 23 (3), pp. 327-335. Date of Electronic Publication: 2023 Jan 26.